We're here for you during the COVID-19 outbreak. Click here for resources.
GAMMAGARD LIQUID is a ready-to-use liquid medicine that is given in a vein (intravenously) or under the skin (subcutaneously) to treat primary immunodeficiency (PI) in people 2 years and older and given in a vein to treat multifocal motor neuropathy (MMN) in adults.
Having a better understanding of your condition is an important part of managing it.
Manage your treatment by learning how you can be more involved in your care.Get Started Now
For PI: See which method of administration may be right for you. Learn more.
For MMN: Learn more about the first and only MMN treatment for adults that improved functioning by effectively maintaining and improving muscle strength, and reducing disability, compared to placebo.1
OnePath is a free program that provides dedicated product support to eligible people who have been prescribed GAMMAGARD LIQUID.
Reference: 1. GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% [Prescribing Information].
Westlake Village, CA: Baxalta US Inc.
You are being directed to another website.Return to
The browser window or tab for Gammagard.com will remain open underneath the new browser window or tab. To return to Gammagard.com at any time, close this tab or window.Return to
The people we serve are our highest priority.
We are here as you navigate challenges during the COVID-19 outbreak. Stay updated on COVID-19
For questions about financial assistance, navigating health insurance, or administration training, please reach out to OnePath support. Get answers from OnePath Support
This manufacturer's coupon program is not valid for prescriptions reimbursed, in whole or in part, by Medicaid, Medicare, Medigap, VA, DoD, TRICARE, or any other federal or state healthcare programs, including state pharmaceutical assistance programs, and where prohibited by the health insurance provider or by law
Shire's MyIgCoPayCard program provides a maximum total benefit of $5,000 for eligible out-of-pocket costs and expires 12 months from date of activation. Eligible costs include deductible, copayment, and co-insurance costs for eligible Shire IG (Immunoglobulin) products. Non-medication expenses, such as ancillary supplies or administration-related costs, are not eligible.
To be eligible, patients must: 1. be starting or receiving treatment with (and have current prescription for) an eligible Shire IG product with an ICD-10 for a diagnosis of Primary Immunodeficiency; and 2. have commercial insurance that covers medication costs for prescribed Shire IG product and allows for CoPay assistance; and 3. be two (2) years old or older.
Acceptance of this offer must be consistent with the terms of benefits provided by patient's health insurance provider.
Offer limited to one card per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, or other offer.
This program is only valid for residents of the United States.
Shire reserves the right to change or discontinue this program at any time without notice.
This is not health insurance.
Add to patient instructions:
If your insurance situation changes, it is your responsibility to notify MyIgSource's CoPay assistance program.
© 2017 Shire. All rights reserved.
SHIRE and the Shire Logo are registered trademarks of Shire Pharmaceutical Holdings Ireland Limited or its affiliates. Gammagard Liquid is a trademark or registered trademark of Baxalta Incorporated, a wholly owned, indirect subsidiary of Shire plc.
What is the most important information that I should know about GAMMAGARD LIQUID?
GAMMAGARD LIQUID can cause the following serious reactions: severe allergic reactions causing difficulty in breathing or skin rashes; decreased kidney function or kidney failure; blood clots in the heart, brain, lungs or elsewhere in the body; severe headache, drowsiness, fever, painful eye movements, or nausea and vomiting; dark colored urine, swelling, fatigue, or difficulty breathing.